WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001087236) TOPICAL ADMINISTRATION OF PHARMACOLOGICAL COMPOSITIONS FOR NON-SYSTEMIC TREATMENT OF PRURITUS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/087236    International Application No.:    PCT/US2001/016100
Publication Date: 22.11.2001 International Filing Date: 17.05.2001
Chapter 2 Demand Filed:    14.11.2001    
IPC:
A61K 9/12 (2006.01), A61K 31/335 (2006.01), A61K 31/4535 (2006.01), A61K 31/495 (2006.01)
Applicants: KLEIN, Gerald, L. [US/US]; (US)
Inventors: KLEIN, Gerald, L.; (US)
Agent: FISH, Robert, D.; Fish & Associates, LLP 1440 N. Harbor Blvd. Suite 706 Fullerton, CA 92835 (US)
Priority Data:
60/204,839 17.05.2000 US
Title (EN) TOPICAL ADMINISTRATION OF PHARMACOLOGICAL COMPOSITIONS FOR NON-SYSTEMIC TREATMENT OF PRURITUS
(FR) ADMINISTRATION TOPIQUE DE COMPOSITIONS PHARMACOLOGIQUES DANS LE TRAITEMENT NON SYSTEMIQUE DU PRURIT
Abstract: front page image
(EN)A pharmacological composition includes an anti-histaminic in spray formulation that reduces symptomatic skin itching of skin without substantially eliciting weight gain or sedation in the patient when the composition is sprayed onto the area of skin at a dosage of at least 10 mg/ml over a period of at least 10 applications. Particularly contemplated anti-histaminic include hydroxyzine and ketotifen.
(FR)L'invention concerne une composition pharmacologique qui comprend un anti-histaminique en spray qui réduit l'irritation cutanée symptomatique sans sensiblement éliciter la prise de poids ou la sédation chez un patient lorsque la composition est pulvérisée sur la zone cutanée à un dosage d'au moins 10mg/ml sur une période d'au moins 10 applications. Parmi les anti-histaminiques plus particulièrement étudiés, figurent l'hydroxyzine et le kétotifène.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)